BioPharma APAC

FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial

Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to proceed with ...

December 23, 2022 | News

STADA partners with BIAL to bring Ongentys to Parkinson’s patients in Australia

STADA receives from BIAL exclusive rights to market and distribute Ongentys (opicapone) capsules in Australia STADA Specialty Head Bryan Kim: "Ongentys ...

December 19, 2022 | News

DAILY rates from anxiety disorders by age, World, 1990 to 2019

...

December 15, 2022 | Analysis

Mental Health

For 2017 this study estimates that 792 million people lived with a mental health disorder. This is slightly more than one in ten people globally (10.7%...

December 15, 2022 | Analysis | By by Saloni Dattani, Hannah Ritchie and Max Roser This article was first published in April 2018. Last updated in August 2021.

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Actinogen Medical Limited (ASX: ACW) is pleased to announce that the first patient has been randomized and treated in the XanaCIDD Phase 2 depression ...

December 15, 2022 | News

Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme

Cogo is a patented and scientifically validated digital therapeutic programme that aims to equip parents with an evidence-backed tool that is efficacious i...

December 06, 2022 | News

Closer Study of Major Autism Gene Suggests Possible Treatment Approach

Research led by a scientist at Cincinnati Children's who primarily studies brain tumors may open doors for improved treatment of autism. Autism spec...

September 26, 2022 | News

Software Identifies Unreported Mental Health Issues in Teens

Advanced Metrics and Samaritan Counseling Center today announced the release of QUALO Behavioral Health, a cloud-based software designed to proactively scr...

August 26, 2022 | News

Persistent Loss of Smell Due to Covid-19 Closely Connected to Long-Lasting Cognitive Problems

Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may...

August 01, 2022 | News

Heart muscle scarring found in patients with hypertension are associated with worse outcomes

First-of-its-kind study by NHCS researchers shows adverse association between heart muscle scarring (also known as myocardial fibrosis) and patients with...

July 21, 2022 | News

Inteleos and Kenya Women and Children's Wellness Center Partner to Reduce Maternal and Fetal Mortality

Inteleos™, a non-profit global healthcare certification organization, and the Kenya Women and Children's Wellness Center (KWCWC) sign...

July 21, 2022 | News

Intellect engages with MSIG Hong Kong to provide holistic mental health support to their policyholders

The market-leading insurance company saw the need for a personalised and comprehensive platform that would address the issue ...

July 05, 2022 | Opinion

NHSA Launches Initiative to Support Mental Health for Head Start Workforce

Starling Minds is a leading digital mental health platform that delivers confidential, unlimited, and personalized training and support to help alleviate s...

June 29, 2022 | News

COVID-19 causes increased risk of developing neurodegenerative disorders

Covid-19-positive outpatients have a higher risk of neurodegenerative disorders compared to people who tested negative for the virus, a new study presented...

June 27, 2022 | News

Stay Connected